MUC1, a high molecular weight glycoprotein, has been identified as a potential biomarker for RCC, which including cellular proliferation, metabolic reprogramming, and angiogenesis—processes that are essential for the progression of RCC (48). This evidence concerns the gene MUC1 and renal cell adenocarcinoma.